- Home
- CAKE vs CNTA Comparison
CAKE vs CNTA Comparison
Compare CAKE & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAKE
- CNTA
- Stock Information
- Founded
- CAKE 1972
- CNTA 2020
- Country
- CAKE United States
- CNTA United Kingdom
- Employees
- CAKE N/A
- CNTA N/A
- Industry
- CAKE Restaurants
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- CAKE Consumer Discretionary
- CNTA Health Care
- Exchange
- CAKE Nasdaq
- CNTA Nasdaq
- Market Cap
- CAKE 2.5B
- CNTA 2.3B
- IPO Year
- CAKE 1992
- CNTA 2021
- Fundamental
- Price
- CAKE $50.39
- CNTA $17.60
- Analyst Decision
- CAKE Hold
- CNTA Strong Buy
- Analyst Count
- CAKE 16
- CNTA 7
- Target Price
- CAKE $47.33
- CNTA $23.71
- AVG Volume (30 Days)
- CAKE 1.0M
- CNTA 688.3K
- Earning Date
- CAKE 10-29-2024
- CNTA 11-12-2024
- Dividend Yield
- CAKE 2.15%
- CNTA N/A
- EPS Growth
- CAKE 52.49
- CNTA N/A
- EPS
- CAKE 2.64
- CNTA N/A
- Revenue
- CAKE $3,537,745,000.00
- CNTA $6,853,000.00
- Revenue This Year
- CAKE $5.97
- CNTA N/A
- Revenue Next Year
- CAKE $5.40
- CNTA N/A
- P/E Ratio
- CAKE $19.47
- CNTA N/A
- Revenue Growth
- CAKE 2.39
- CNTA N/A
- 52 Week Low
- CAKE $31.24
- CNTA $6.65
- 52 Week High
- CAKE $52.10
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- CAKE 57.81
- CNTA 54.64
- Support Level
- CAKE $49.33
- CNTA $15.88
- Resistance Level
- CAKE $51.80
- CNTA $17.34
- Average True Range (ATR)
- CAKE 1.53
- CNTA 0.92
- MACD
- CAKE -0.13
- CNTA -0.10
- Stochastic Oscillator
- CAKE 55.47
- CNTA 55.66
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.